The Discounted Cash Flow (DCF) valuation of Reyon Pharmaceutical Co Ltd (102460.KS) is (7,296.56) KRW. With the latest stock price at 11,960.00 KRW, the upside of Reyon Pharmaceutical Co Ltd based on DCF is -161.0%.
Based on the latest price of 11,960.00 KRW and our DCF valuation, Reyon Pharmaceutical Co Ltd (102460.KS) is a sell. selling 102460.KS stocks now will result in a potential gain of 161.0%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 4.7% - 7.1% | 5.9% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (8,967.30) - 19,982.64 | (7,296.56) |
| Upside | -175.0% - 67.1% | -161.0% |